Yano et al., “Tin-117m: Production, Chemistry and Evaluation as a Bone-Scanning Agent,” International Journal of Applied Radiation and Isotopes, vol. 24, pp. 319-325, 1973.* |
Atkins et al., “Biodistribution of Sn-117m (4+) DTPA for Palliation Therapy of Painful Osseous Metastases,” 186, Radiology, pp. 279-283, 1993.* |
Oster et al., “The Development and In-Vivo Behavior of Tin Containing Radiopharmaceuticals-II. Autoradiographic and Scintigraphic Studies in Normal Animals and in Animal Models of Bone Disease,” Int. J. Nucl. Med. Biol., vol. 12, No. 3, pp. 175-184 (1985). |
Srivastava et al. “The Development and In-Vivo Behavior of Tin Containing Radiopharmaceuticals-I. Chemistry, Preparation, and Biodistribution in Small Animals,” Int. J. Nucl. Med. Biol., vol. 12, No. 3, pp. 167-174 (1985). |
Atkins et al., “Tin-117m(4+)-DTPA for Palliation of Pain from Osseous Metastases: A Pilot Study,” The Journal of Nuclear Medicine, vol. 36, No. 5 (1995). |
Srivastava, et al., “Treatment of Metastatic Bone Pain with Tin-117m Stannic Diethylenetriaminepentaacetic Acid: A Phase I/II Clinical Study,” Clinical Cancer Research, vol. 4, pp. 61-68 (1998). |